• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


9.7600 USD 0.0600 0.62%

As of 20:10:00 ET on 09/17/2014.

Snapshot for uniQure B.V. (QURE)

Open: 9.6400 Day's Range: 9.5600 - 9.9000 Volume: 10,337
Previous Close: 9.7000 52wk Range: 8.2900 - 18.7500 1-Yr Rtn: -

Stock Chart for QURE

No chart data available.
  • QURE:US 9.7600
  • 1D
  • 1M
  • 1Y
Interactive QURE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for QURE

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (EUr) (ttm) -
Est. EPS (EUr) (12/2014) -196.0630
Est. PEG Ratio -
Market Cap (M USD) 171.73
Shares Outstanding (M) 17.59
30 Day Average Volume 37,261
Price/Book (mrq) 241.1873
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 12/02/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for QURE

  • Revenue
  • Net Income (M/EUr)
  • Profit Margin (%)

Company Profile & Key Executives for QURE

UNIQURE B.V. develops gene therapy products that offer the prospect of long-term and potentially curative benefit to patients with genetic or acquired diseases by directing the expression of a therapeutic protein or restoring the expression of a missing protein through a single administration.

Jorn AldagCEO/Member-Mgmt BoardEric GoossensChief Operating Officer
Hans PreustingChief Business OfficerHans Christian RohdeChief Commercial Officer
More Company Profile & Key Executives for QURE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil